欧洲精准医疗软体市场：依产品类型、应用、最终用户、国家 - 分析与预测（2024-2033）

2024年欧洲精准医疗软体市场规模为4.609亿美元。

预计2024年至2033年该市场将以11.47%的复合年增长率成长，2033年达到12.247亿美元。在欧洲市场，精准医疗软体是指旨在支援医疗保健领域精准医疗实施的先进数位工具和应用程式。这种个体化方法着重于根据患者个体特征（包括遗传、生活方式、环境以及分子或细胞特征）量身定制的治疗和决策。

由于资料分析、基因组学和个人化医疗保健策略的市场开拓，欧洲精准医疗软体市场正在显着扩张。精准医疗软体对于根据每位患者独特的基因谱、生活方式和环境情况量身定制医疗选择和治疗至关重要。透过实现资料主导的决策，该技术可以改善患者的治疗效果、治疗效果和诊断准确性。

欧洲强大的医疗保健系统和对数位健康倡议的投资增加推动了精准医疗软体的采用。透过「地平线欧洲」等项目，欧洲各国政府和组织正在将基因研究和精准医学作为首要任务，并推动该领域的创新。人工智慧（AI）和机器学习（ML）的整合进一步增强了软体的功能，实现即时资料分析和客製化治疗计划。

在欧洲，药物基因体学、慢性病管理、罕见疾病发现和肿瘤学是精准医学软体的主要用途。儘管存在资料隐私问题和高昂的实施成本等障碍，但随着生物资讯学和巨量资料的市场开拓，对精准医疗的日益重视正在推动市场扩张。

该报告研究了欧洲精准医疗软体市场，并提供了市场概况，包括按产品类型、应用、最终用户、国家和参与市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场

• 趋势：当前和未来的影响评估
• 供应链概览
• 监管状况
• 市场动态概览

第二章 区域

• 区域概况
• 促进因素和抑制因素
• 欧洲

第三章 市场竞争基准化分析及公司概况

• 未来展望
• 地理评估
  • F. Hoffmann-La Roche Ltd
  • Genedata AG
  • Koninklijke Philips NV
  • QIAGEN NV
  • SOPHiA GENETICS SA

第四章调查方法

Introduction to Europe Precision Medicine Software Market

The Europe precision medicine software market was valued at $460.9 million in 2024 and is expected to reach $1,224.7 million by 2033, growing at a CAGR of 11.47% between 2024 and 2033. In the Europe market, precision medicine software refers to advanced digital tools and applications designed to support the implementation of precision medicine in healthcare. This personalized approach focuses on tailoring medical treatments and decisions to individual patient characteristics, including genetics, lifestyle, environment, and molecular or cellular profiles.

Market Introduction

The market for precision medicine software in Europe is expanding significantly due to developments in data analytics, genomics, and tailored healthcare strategies. In order to customize medical choices and treatments to each patient's unique genetic profile, lifestyle, and environmental circumstances, precision medicine software is essential. By enabling data-driven decision-making, this technology enhances patient outcomes, treatment effectiveness, and diagnostic precision.

Precision medicine software adoption is being accelerated by Europe's strong healthcare system and rising investments in digital health initiatives. Through programs like Horizon Europe, governments and organizations throughout the continent are giving genetic research and precision healthcare top priority, which is encouraging innovation in the field. The software's capabilities are further improved by the integration of artificial intelligence (AI) and machine learning (ML), which permits real-time data analysis and customized treatment planning.

In Europe, pharmacogenomics, chronic disease management, uncommon disease detection, and oncology are among the main uses of precision medicine software. The increased emphasis on precision healthcare, along with developments in bioinformatics and big data, is propelling market expansion despite obstacles such data privacy issues and high implementation costs.

The market for precision medicine software is expected to be crucial in improving patient care and advancing personalized medicine, as Europe continues to lead the world in the adoption of cutting-edge healthcare technologies.

Market Segmentation

Segmentation 1: by Delivery Mode

• On-Premises Delivery Mode
• Cloud-Based Delivery Mode

Segmentation 2: by Application

• Oncology
• Cardiovascular
• Rare Diseases
• Others

Segmentation 3: by End User

• Healthcare Providers
• Research Centers and Government Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

Segmentation 4: by Country

• Germany
• U.K.
• France
• Italy
• Spain
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe precision medicine software market has been segmented based on various categories, such as product type, application, and end user.

Competitive Strategy: The Europe precision medicine software market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the precision medicine software market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• F. Hoffmann-La Roche Ltd
• Genedata AG
• Koninklijke Philips N.V.
• QIAGEN N.V.
• SOPHiA GENETICS SA

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Rise in Personalized Healthcare
  • 1.1.2 Cloud-Based Delivery Mode-Based Platforms Elevating Data Accessibility
• 1.2 Supply Chain Overview
  • 1.2.1 Value Chain Analysis
• 1.3 Regulatory Landscape
• 1.4 Market Dynamics Overview
  • 1.4.1 Market Drivers
    • 1.4.1.1 Utilizing Artificial Intelligence and Precision Medicine Together
    • 1.4.1.2 Enhancement in the Precision Medicine Field Using Integrated and Automated Solutions
  • 1.4.2 Market Restraints
    • 1.4.2.1 Data Safety and Privacy Concerns
  • 1.4.3 Market Opportunities
    • 1.4.3.1 Leveraging Electronic Health Records in the Market

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Europe
  • 2.3.1 Regional Overview
  • 2.3.2 Driving Factors for Market Growth
  • 2.3.3 Factors Challenging the Market
  • 2.3.4 Application
  • 2.3.5 Product
  • 2.3.6 France
  • 2.3.7 Germany
  • 2.3.8 U.K.
  • 2.3.9 Spain
  • 2.3.10 Italy
  • 2.3.11 Rest-of-Europe

3 Markets Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Geographic Assessment
  • 3.2.1 F. Hoffmann-La Roche Ltd
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products/Product Portfolio
    • 3.2.1.3 Target Customers
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Genedata AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products/Product Portfolio
    • 3.2.2.3 Target Customers
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View
  • 3.2.3 Koninklijke Philips N.V.
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products/Product Portfolio
    • 3.2.3.3 Target Customers
    • 3.2.3.4 Key Personnel
    • 3.2.3.5 Analyst View
  • 3.2.4 QIAGEN N.V.
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products/Product Portfolio
    • 3.2.4.3 Target Customers
    • 3.2.4.4 Key Personnel
    • 3.2.4.5 Analyst View
  • 3.2.5 SOPHiA GENETICS SA
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products/Product Portfolio
    • 3.2.5.3 Target Customers
    • 3.2.5.4 Key Personnel
    • 3.2.5.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Precision Medicine Software Market (by Region), $Million, 2023, 2027, and 2033
• Figure 2: Europe Precision Medicine Software Market (by Delivery Mode), $Million, 2023, 2027, and 2033
• Figure 3: Europe Precision Medicine Software Market (by Application), $Million, 2023, 2027, and 2033
• Figure 4: Europe Precision Medicine Software Market (by End User), $Million, 2023, 2027, and 2033
• Figure 5: Key Events of Precision Medicine Software Market, 2023 and 2024
• Figure 6: Role of Precision Medicine Software in Personalized Care
• Figure 7: Benefits of Using Cloud-Based Delivery Mode Technology in Healthcare
• Figure 8: Supply Chain and Risks within the Supply Chain
• Figure 9: Precision Medicine Software (by Year), January 2021-December 2023
• Figure 10: Impact Analysis of Market Navigating Factors, 2023-2033
• Figure 11: Benefits of Integrating AI with Precision Medicine
• Figure 12: Two Key Strategies for Empowering Precision Medicine
• Figure 13: France Precision Medicine Software Market, $Million, 2023-2033
• Figure 14: Germany Precision Medicine Software Market, $Million, 2023-2033
• Figure 15: U.K. Precision Medicine Software Market, $Million, 2023-2033
• Figure 16: Spain Precision Medicine Software Market, $Million, 2023-2033
• Figure 17: Italy Precision Medicine Software Market, $Million, 2023-2033
• Figure 18: Rest-of-Europe Precision Medicine Software Market, $Million, 2023-2033
• Figure 19: Strategic Initiatives, 2021-2023
• Figure 20: Share of Strategic Initiatives, 2021-2023
• Figure 21: Data Triangulation
• Figure 22: Top-Down and Bottom-Up Approach
• Figure 23: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Precision Medicine Software Market Trend Analysis
• Table 4: Cloud-Based Delivery Mode-Based Platform
• Table 5: Role of EHRs in Advancing Precision Medicine
• Table 6: Precision Medicine Software (by Region), $Million, 2023-2033
• Table 7: Europe Precision Medicine Software Market (by Application), $Million, 2023-2033
• Table 8: Europe Precision Medicine Software Market (by End User), $Million, 2023-2033
• Table 9: Europe Precision Medicine Software Market (by Delivery Mode), $Million, 2023-2033